Johnson & Johnson (NYSE:JNJ) had its price objective trimmed by Barclays from $62.00 to $60.00 in a research report released on Monday morning, AnalystRatings.Net reports. Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a neutral rating on shares of Johnson & Johnson in a research note to […]
Johnson & Johnson PT Lowered to $60.00 (JNJ) is a post from: Zolmax
The post Johnson & Johnson PT Lowered to $60.00 (JNJ) appeared first on Zolmax.